a breakthrough therapy: polatuzumab vedotin plus br for r/r dlbcl
Published 6 years ago • 2.2K plays • Length 4:59Download video MP4
Download video MP3
Similar videos
-
5:46
glofitamab and polatuzumab vedotin in dlbcl
-
2:31
long-term follow up of study of obinutuzumab, polatuzumab vedotin, and lenalidomide in r/r fl
-
3:13
treatment using mosunetuzumab with or without obinutuzumab and polatuzumab vedotin in fl and mzl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
7:31
t-cell lymphoma with barbara pro, md | everything you need to know
-
16:33
항체가 그냥 커피라면, 항체-약물결합체는 top야...!! 브렌툭시맙베도틴(brentuximab vedotin)과 폴라투주맙베도틴(polatuzumab vedotin)
-
1:51:17
neet-ss september 2022 recall - hematology | dr. sumeet mirgh | marrow super speciality
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:03
insights into the cartitude-6 trial: rationale and design
-
1:24
the long-term safety and efficacy of ibrutinib monotherapy in patients with previously-treated wm
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
1:19
the potential of caplacizumab in the treatment of attp
-
1:01
pitfalls in the diagnosis of lymphoid malignancies: interpreting pet scans
-
1:39
overview of the cllr3 trial of obinutuzumab
-
0:50
insights into the phase ii window-2 trial
-
2:41
an overview of the latest advances in hematology
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:35
update on phase i study of plamotamab in r/r nhl